← 返回首页
大洋洲 · 新闻 · The Mercury

Optiscan’s digital pathology tech hits major US FDA milestone

来源：The Mercury · 澳大利亚 16 小时前

Optiscan Imaging has hit a major US regulatory milestone, lodging its FDA 510(k) submission for InForm and moving the digital pathology device into formal review.

在 The Mercury 阅读全文 登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.themercury.com.au)

推荐阅读

The Age

Revealed: Hawks’ opening offer for Merrett as trade war resumes

 Brisbane Times

Revealed: Hawks’ opening offer for Merrett as trade war resumes

 WAtoday

Revealed: Hawks’ opening offer for Merrett as trade war resumes

 PerthNow

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

 The Conversation AU

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

 The Guardian Australia

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns